Lucid Diagnostics Inc. (LUCD) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2025-09-30..
Gross margin
Overview →Financial period ending 2025-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2025-09-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 4.40M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2025-09-30 | (m) | $4.40M | (m) | (m) |
| 2025-06-30 | (m) | $4.36M | (m) | (m) |
| 2025-03-31 | (m) | $4.17M | (m) | (m) |
| 2024-12-31 | (m) | $4.35M | (m) | (m) |
| 2024-09-30 | (m) | $4.19M | (m) | (m) |
| 2024-06-30 | (m) | $3.80M | (m) | (m) |
| 2024-03-31 | (m) | $2.98M | (m) | (m) |
| 2023-12-31 | (m) | $2.43M | (m) | (m) |
| 2023-09-30 | (m) | $1.50M | (m) | (m) |
| 2023-06-30 | (m) | $793.00K | (m) | (m) |
| 2023-03-31 | (m) | $634.00K | (m) | (m) |
| 2022-12-31 | $377.00K | $377.00K | $100.00M | 100.00% |
| 2022-09-30 | $-20.00K | $565.00K | (m) | -3.54% |
| 2022-06-30 | $-265.00K | $689.00K | (m) | -38.46% |
| 2022-03-31 | (m) | (m) | (m) | (m) |
| 2021-12-31 | $-85.00K | $500.00K | (m) | -17.00% |
| 2021-09-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |